Approved PLCO Projects
Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.
| Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
|---|---|---|---|---|---|
| Circulating Estrogens, Androgens, and Progestogens and Risk of Breast Cancer in the PLCO Cohort | Regina Ziegler | National Cancer Institute | PLCO | Jun 29, 2017 | 2017-0029 |
| Blood metabolite profiles and risk of developing endometrial cancer | Mary Playdon | Huntsman Cancer Institute | PLCO | Jun 29, 2017 | 2017-0020 |
| Evaluation of effects of dietary factors on the risk of colorectal cancer | Meilin Wang | Nanjing Medical Univeristy | PLCO | Jun 15, 2017 | PLCO-280 |
| Using Big Data for Computer-Aided Diagnosis of Chest X-Rays | Ronald Summers | National Institutes of Health Clinical Center | PLCO | Jun 9, 2017 | PLCO-279 |
| Towards Precision Prevention: Testing a Machine Learning Algorithm in Pancreatic Cancer | Shannon Lynch | Fox Chase Cancer Center | PLCO | May 30, 2017 | PLCO-277 |
| Deep Learning for Pathology Detection in Chest X-Rays | Ivo Matteo Baltruschat | University Medical Center Hamburg-Eppendorf | PLCO | May 24, 2017 | PLCO-275 |
| Association of Coffee Drinking with Leukocyte Telomere Length | Erikka Loftfield | Yale School of Public Health | PLCO | May 24, 2017 | PLCO-271 |
| A metabolomic analysis of multiple myeloma development and progression | Jonathan Hofmann | National Cancer Institute | PLCO | May 23, 2017 | 2016-0009 |
| Deep Learning for Pathology Image Analysis | Lily Peng | PLCO | May 16, 2017 | PLCO-257 | |
| Effect of Dietary Omega-3 fatty acids and GPR120 Single Nucleotide Polymorphisms on Prostate Cancer Chemoprevention | William Aronson | University of California Los Angeles | PLCO | May 8, 2017 | PLCO-274 |
| Primary treatment assignment, time-to-treatment, and prostate cancer outcomes in PLCO | Dudith Pierre-Victor | National Cancer Institute | PLCO | May 3, 2017 | PLCO-273 |
| Defining the role of lipids and metabolic factors as risk factor for prostate cancer and prostate cancer aggressiveness. A PhD project | Adel Aref | The University of Adelaide Freemasons Foundation Centre for Men’s Health South Australian Health and Medical Research Institute | PLCO | Apr 20, 2017 | PLCO-272 |
| Melanoma GWAS | Maria Teresa Landi | NIH, NCI | PLCO | Apr 5, 2017 | PLCO-268 |
| Efficient estimation of AUC in nested case-control studies | Anil Chaturvedi | National Cancer institute | PLCO | Mar 31, 2017 | PLCO-269 |
| Germline genetics of metastasis: an across cancer analysis | Lisa Mirabello | National Cancer Institute, NIH | PLCO | Mar 29, 2017 | PLCO-267 |
| A case-crossover study of air pollution exposure and lung cancer related mortality in PLCO | Jason Wong | National Cancer Institute | PLCO | Mar 24, 2017 | PLCO-264 |
| The use of marginal structural model to determine the effect of non-steroidal anti-inflammatory drug use on the risk of prostate and ovarian cancer | Omonefe Omofuma | University of south Carolina | PLCO | Mar 17, 2017 | PLCO-265 |
| Molecular characterization of bladder tumors and studies of etiologic heterogeneity in the PLCO Trial | Stella Koutros | National Cancer Institute | PLCO | Mar 14, 2017 | 2016-0045 |
| Pancreatic Cancer Prediction using Machine Learning | Akshay Bodkhe | San Jose State University | PLCO | Mar 2, 2017 | PLCO-259 |
| PSA velocity and prostate cancer mortality in the PLCO Cancer Screening Trial | Kathryn Barry | University of Maryland School of Medicine | PLCO | Mar 1, 2017 | PLCO-261 |